A groundbreaking study has shown that human genes can be influenced and controlled using electricity, offering a significant advancement in the development of wearable devices capable of programming genes to execute medical interventions.

The research successfully triggered insulin production in human cells by employing an innovative “electrogenetic” interface that activates targeted genes through electrical currents.

This remarkable breakthrough opens up possibilities for future applications of the interface, enabling the delivery of therapeutic doses for treating various conditions, including diabetes, by directly manipulating human DNA using electricity.

The potential for medical wearables is now gaining considerable attention, encompassing health-centric portable technologies like fitness trackers, biosensors, blood pressure monitors, and portable electrocardiogram devices, Vice News reported.

These smart wearables have already proven to be invaluable tools for doctors and patients alike, prompting scientists to explore novel platforms for collecting medical data and performing medical interventions.

The team of scientists, led by molecular biologist Jinbo Huang from ETH Zürich, has devised a battery-powered interface known as “the direct current (DC)-actuated regulation technology” or DART.

This groundbreaking invention has been described as “the missing link” that could enable wearable devices to control genes in the near future.

The study, published in Nature, showcases the potential of this technology in shaping the future of medical interventions and personalized treatments.

Written by staff